LLY

949.03

+1.48%↑

NVO

142.18

+1.62%↑

UNH

511.99

+1.33%↑

JNJ

149.82

+0.04%↑

MRK

127.38

-1.16%↓

LLY

949.03

+1.48%↑

NVO

142.18

+1.62%↑

UNH

511.99

+1.33%↑

JNJ

149.82

+0.04%↑

MRK

127.38

-1.16%↓

LLY

949.03

+1.48%↑

NVO

142.18

+1.62%↑

UNH

511.99

+1.33%↑

JNJ

149.82

+0.04%↑

MRK

127.38

-1.16%↓

LLY

949.03

+1.48%↑

NVO

142.18

+1.62%↑

UNH

511.99

+1.33%↑

JNJ

149.82

+0.04%↑

MRK

127.38

-1.16%↓

LLY

949.03

+1.48%↑

NVO

142.18

+1.62%↑

UNH

511.99

+1.33%↑

JNJ

149.82

+0.04%↑

MRK

127.38

-1.16%↓

Search

BioNTech SE ADR

Suletud

Sektor Tervishoid

84.84 0.13

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

83.42

Max

86.89

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+32.76 upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

5. aug 2024

Uudiste sentiment

By Acuity

50%

50%

117 / 369 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Strong Bullish Evidence

BioNTech SE ADR Graafik

Seotud uudised

6. mai 2024, 11:27 UTC

Tulu

BioNTech Swings to Net Loss on Lower Covid Vaccine Sales

20. märts 2024, 10:44 UTC

Tulu

BioNTech Profit Slumps on Lower Covid Vaccine Sales

8. veebr 2024, 11:43 UTC

Omandamised, ülevõtmised, äriostud

BioNTech Agrees To Invest $200 Million in Autolus, Starts Strategic Collaboration

9. jaan 2024, 19:42 UTC

Suurimad hinnamuutused turgudel

BioNTech Shares Down 3.4%; Sees 2024 Revenue Below Wall Street Views

19. dets 2023, 16:57 UTC

Suurimad hinnamuutused turgudel

CureVac Shares Hit All-Time Low on German Patent Court Ruling

13. dets 2023, 13:16 UTC

Suurimad hinnamuutused turgudel

Moderna Shares, Other Covid Vaccine Makers Hit by Warning From Pfizer

6. nov 2023, 19:07 UTC

Tulu

Trending: BioNTech Reports Surprise Profit, Cuts Outlook

6. mai 2024, 20:15 UTC

Tulu

BioNTech Lifts As Covid Sales Plummet With 90% Of Revenue Still To Come -- IBD

6. mai 2024, 10:47 UTC

Tulu

BioNTech Sees FY24 Rev EUR2.5B-EUR3.1B >BNTX

6. mai 2024, 10:46 UTC

Tulu

Correct: BioNTech 1Q Loss/Shr EUR1.31 >BNTX

6. mai 2024, 10:46 UTC

Tulu

Correct: BioNTech 1Q Loss EUR315.1M >BNTX

6. mai 2024, 10:46 UTC

Tulu

Correct: BioNTech 1Q Rev EUR187.6M >BNTX

6. mai 2024, 10:45 UTC

Tulu

BioNTech 1Q Rev $187.6M >BNTX

6. mai 2024, 10:45 UTC

Tulu

BioNTech 1Q Loss $315.1M >BNTX

6. mai 2024, 10:45 UTC

Tulu

BioNTech 1Q Loss/Shr $1.31 >BNTX

26. märts 2024, 05:00 UTC

Tulu

This Vaccine Maker Sits on Cash Almost Equal to Its Market Value -- Barrons.com

20. märts 2024, 11:44 UTC

Tulu

BioNTech Earnings Fall Short of Estimates. The Stock Is Down. -- Barrons.com

20. märts 2024, 10:27 UTC

Tulu

BioNTech's Stock Sinks After Earnings Fall Below Expectations, Hurt By Writedowns Of Vaccine Inventory -- MarketWatch

20. märts 2024, 10:17 UTC

Tulu

BioNTech 4Q Rev EUR1.48B >BNTX

20. märts 2024, 10:15 UTC

Tulu

Biontech 4Q Net Pft EUR457.9M

20. märts 2024, 10:15 UTC

Tulu

Biontech Plans For Ten or More Registrational Oncology Trials By End of 2024

20. märts 2024, 10:15 UTC

Tulu

Biontech: Annemarie Hanekamp appointed to Management Board as Chief Commercial Officer, effective Jul. 1

20. märts 2024, 10:15 UTC

Tulu

Biontech Aims For First Oncology Launch in 2026 and Ten Indication Approvals by 2030

20. märts 2024, 10:15 UTC

Tulu

Biontech 2023 Gross Profit For COVID-19 Vaccine Business EUR3.2B

20. märts 2024, 10:15 UTC

Tulu

Biontech Sees 2024 Revenue Between EUR2.5B - EUR3.1B

20. märts 2024, 10:15 UTC

Tulu

Biontech 4Q Rev EUR1.48B

8. veebr 2024, 11:28 UTC

Omandamised, ülevõtmised, äriostud

BioNTech Agrees To Invest $200 Mln in Autolus, Starts Strategic Collaboration

9. jaan 2024, 19:27 UTC

Suurimad hinnamuutused turgudel

BioNTech Shares Down 3.4%; Sees 2024 Rev Below Wall Street Views

15. dets 2023, 16:44 UTC

Tulu
Omandamised, ülevõtmised, äriostud

Barron's Favorite 10 Stocks for 2024 -- -2-

15. dets 2023, 16:44 UTC

Tulu
Omandamised, ülevõtmised, äriostud

Barron's Favorite 10 Stocks for 2024 -- Barrons.com

Võrdlus sarnastega

Hinnamuutus

BioNTech SE ADR Prognoos

Hinnasiht

By TipRanks

32.76% tõus

12 kuu keskmine prognoos

Keskmine 112.45 USD  32.76%

Kõrge 171 USD

Madal 90 USD

Põhineb 13 Wall Streeti analüütiku instrumendi BioNTech SE ADR 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

13 ratings

5

Osta

7

Hoia

1

Müü

Tehniline skoor

By Trading Central

80.02 / 84.7Toetus ja vastupanu

Lühikene perspektiiv

Strong Bullish Evidence

Keskpikk perspektiiv

Weak Bearish Evidence

Pikk perspektiiv

Bearish Evidence

Sentiment

By Acuity

117 / 369 Pingereas Tervishoid

Uudiste sentiment

Neutral

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Keskmine